We are live on ! Find out more
WSA

Wall Street Associates Portfolio holdings

AUM $151M
1-Year Est. Return 30.3%
This Fund
S&P 500
This Quarter Est. Return
+12.91%
1 Year Est. Return
+30.3%
3 Year Est. Return
+94.41%
5 Year Est. Return
10 Year Est. Return
AUM
$1.06B
AUM Growth
+$2.09M
Cap. Flow
-$58.5M
Cap. Flow %
-5.52%
Top 10 Hldgs %
16.9%
Holding
379
New
57
Increased
31
Reduced
195
Closed
48

Sector Composition

Rank Sector Weight
1 Healthcare 32.07%
2 Technology 23.74%
3 Consumer Discretionary 15.43%
4 Industrials 9.57%
5 Communication Services 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADPT
1
DELISTED
Adeptus Health Inc
ADPT
$25.8M 2.44%
272,128
+16,228
+6% +$1.12M
TWOU
2
DELISTED
2U Inc
TWOU
$21.1M 1.98%
21,808
+610
+3% +$506K
CALD
3
DELISTED
Callidus Software, Inc.
CALD
$19.8M 1.86%
1,268,393
-25,889
-2% -$369K
RGEN icon
4
Repligen
RGEN
$9.95B
$18.9M 1.78%
456,800
-240,800
-35% -$8.82M
TVTX icon
5
Travere Therapeutics
TVTX
$6.19B
$18.3M 1.72%
550,795
-9,900
-2% -$271K
BFX
6
DELISTED
BowFlex Inc.
BFX
$16.5M 1.56%
767,800
-13,600
-2% -$270K
GTT
7
DELISTED
GTT Communications, Inc.
GTT
$15.9M 1.5%
664,827
-97,703
-13% -$1.99M
AAC
8
DELISTED
AAC Holdings
AAC
$15.3M 1.44%
350,995
+37,146
+12% +$1.37M
RENT
9
DELISTED
RENTRAK CORP
RENT
$14.2M 1.33%
202,800
-3,200
-2% -$193K
QTWO icon
10
Q2 Holdings
QTWO
$4.06B
$13.7M 1.29%
484,122
+132,812
+38% +$3.1M
QDEL icon
11
QuidelOrtho
QDEL
$1.01B
$13.2M 1.24%
574,200
-10,000
-2% -$233K
PGTI
12
DELISTED
PGT, Inc.
PGTI
$12M 1.13%
825,902
+67,602
+9% +$839K
MXL icon
13
MaxLinear
MXL
$5.6B
$11.9M 1.12%
981,700
+255,900
+35% +$2.57M
ITCI
14
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$11.5M 1.08%
358,857
-6,500
-2% -$165K
EGRX
15
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$11.4M 1.08%
141,300
-20,800
-13% -$1.35M
HASI icon
16
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.14B
$11.3M 1.06%
561,270
+90,200
+19% +$1.76M
CCRN
17
DELISTED
Cross Country Healthcare
CCRN
$11M 1.04%
867,100
-15,400
-2% -$175K
MMI icon
18
Marcus & Millichap
MMI
$1.23B
$10.8M 1.02%
233,989
+79,500
+51% +$3.39M
SCAI
19
DELISTED
Surgical Care Affiliates, Inc.
SCAI
$10.8M 1.02%
281,200
-5,000
-2% -$189K
BLDR icon
20
Builders FirstSource
BLDR
$7.29B
$10.5M 0.99%
820,200
-15,000
-2% -$183K
HSTM icon
21
HealthStream
HSTM
$859M
$10.4M 0.98%
341,300
+57,700
+20% +$1.65M
IMPR
22
DELISTED
IMPRIVATA, INC COM
IMPR
$10.3M 0.97%
630,500
-10,100
-2% -$152K
KTWO
23
DELISTED
K2M Group Holdings, Inc
KTWO
$10.1M 0.96%
422,000
+34,100
+9% +$814K
NGVC icon
24
Vitamin Cottage Natural Grocers
NGVC
$633M
$9.94M 0.94%
403,800
-7,300
-2% -$187K
CNR
25
DELISTED
Cornerstone Building Brands, Inc.
CNR
$9.85M 0.93%
653,496
-82,409
-11% -$1.3M

Similar funds

Wall Street Associates's Q2 2015 Portfolio in Review

As of Q2 2015, Wall Street Associates held 379 positions worth $1.06B, up 0.2% from $1.06B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Wall Street Associates withdrew a net $58.5M in Q2 2015, closing 48 positions and reducing 195 holdings. Its most notable exit was AUSPEX PHARMACEUTICALS INC COM STK (DE), an estimated $32.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Wall Street Associates opened a new position in iShares Russell 2000 Growth ETF worth $7.71M.

  • Wall Street Associates's largest Q2 2015 buy was iShares Russell 2000 Growth ETF: 49,900 shares worth $7.71M.
  • Wall Street Associates added most to Marcus & Millichap in Q2 2015, an estimated $3.39M increase.
  • Wall Street Associates's biggest Q2 2015 reduction was Repligen, cutting an estimated $8.82M.
  • Wall Street Associates fully exited AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q2 2015, selling an estimated $32.7M.
  • Wall Street Associates's ten largest holdings make up 17% of its $1.06B portfolio in Q2 2015.
  • Wall Street Associates opened 57 new positions and closed 48 in Q2 2015.
  • Wall Street Associates's portfolio value rose 0.2% quarter-over-quarter to $1.06B.

Based on Wall Street Associates's 13F filing for Q2 2015, filed 13 Aug 2015.